Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identifying tumor origin using a gene expression-based classification map.

Phillip Buckhaults1, Zhen Zhang, Yu-Chi Chen

  • 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

Cancer Research
|July 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural cues differentially modulate colorectal cancer cell behavior depending on patients' genomic background.

iScience·2026
Same author

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

Cancer discovery·2026
Same author

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

EMBO molecular medicine·2026
Same author

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Cancer discovery·2026
Same author

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

Cancer discovery·2026
Same author

Mapping intratumor heterogeneity across layers for advancing immunotherapy.

Cell·2026

A new gene expression profiling method accurately identifies the origin of metastatic cancers. This approach uses five key genes to classify tumor types, aiding in clinical management of unknown primary cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Identifying the primary tumor site in metastatic carcinoma of unknown origin is crucial for effective patient management.
  • Transcriptional profiling offers potential solutions, but simpler, reliable methods are needed.

Purpose of the Study:

  • To develop and validate a gene expression-based method for determining the tissue of origin in metastatic adenocarcinomas.
  • To identify a minimal set of genes capable of discriminating between different cancer types.

Main Methods:

  • Serial analysis of gene expression (SAGE) libraries were used for initial gene discovery.
  • Quantitative real-time PCR validated gene expression in a cohort of ovarian, breast, colon, and pancreatic adenocarcinomas.
  • Unsupervised cluster analysis and self-organized maps were employed for diagnostic classification.

Related Experiment Videos

Main Results:

  • Five genes were identified with distinct expression patterns differentiating four types of adenocarcinomas.
  • An independent validation set showed 81% accuracy in correctly allocating tumor samples based on these five genes.
  • Metastatic tumors clustered with their corresponding primary tumor types, demonstrating the method's reliability.

Conclusions:

  • A five-gene expression signature derived from SAGE data provides a reliable and practical approach for tumor type classification.
  • This method can aid in determining the primary site of metastatic carcinoma of unknown origin, improving clinical decision-making.